Global Respiratory Inhalers Market Soars to USD 30.8 Billion in 2022, Poised for USD 49.0 Billion Growth by 2030
The global respiratory inhalers market achieved a valuation of USD 30.8 billion in 2022 and anticipates robust expansion, surging to an estimated USD 49.0 billion by 2030. This growth trajectory is underpinned by a projected Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period spanning 2023 to 2030. Essential in managing respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD), respiratory inhalers play a pivotal role in alleviating symptoms such as wheezing, shortness of breath, coughing, and chest tightness by facilitating bronchodilation.
The market's upward trajectory is fueled by several factors, including the escalating prevalence of respiratory disorders globally, augmented demand for advanced treatment options, and the widespread accessibility of cutting-edge technologies. The surge is further propelled by the growing geriatric population, heightened awareness of pulmonary diseases, increased healthcare spending, and the expanding utilization of fluoroscopy in pain management.
Scope and Segmentation
Size Available for Years: 2021-2030
Forecast Period: 2023-2030
Data Availability: Value (US$)
Segments Covered: Technology, Product, Application, End User
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Report Insights Covered:
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Infection Type Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other Key Insights.
1. Rapidly Increasing Prevalence of Respiratory Disorders
The market is propelled by the escalating prevalence of respiratory diseases, with conditions like Asthma, COPD, and pulmonary atrial hypertension on the rise globally. According to the WHO, in 2019, 455,000 asthma-related deaths and 3.2 million annual deaths due to COPD were reported, making it the third-leading cause of death worldwide.
2. Increasing Usage of Combination Therapy
The adoption of combination therapies for asthma, such as the FDA-approved combination of inhaled corticosteroids in January 2023, is driving demand for respiratory inhalers. This novel therapy, combining albuterol and budesonide, relaxes muscles and reduces airway inflammation, significantly lowering the risk of severe asthma attacks.
3. High Cost of Inhalers
The substantial cost of inhalers remains a concern, hindering market growth, particularly in underdeveloped and developing nations where patients may face challenges affording these devices.
Market Segmentation Analysis:
The global respiratory inhalers market is segmented based on technology, product, application, end-user, and region. Notably, dry powder inhalers account for approximately 42.5% of the market share, expected to dominate throughout the forecast period.
For More Insights: www.datamintelligence.com/research-report/respiratory-inhalers-market
North America asserts its dominance, accounting for around 38.6% of the market share in 2022. Asthma affects approximately 26 million people in the US, making it a leading chronic disease.
Major global players in the respiratory inhalers market include Adherium Limited, AstraZeneca plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.P.A, Cipla Inc, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., HELTMAN Medikal A.S, Koninklijke Philips N.V, and others.
In conclusion, the global respiratory inhalers market is poised for substantial growth, driven by a combination of factors, including the rising prevalence of respiratory disorders, advancements in treatment options, and technological accessibility. The market's evolution is characterized by a diverse segmentation and geographical penetration, with North America emerging as a key player.
Cardiac Monitoring Devices Market: www.datamintelligence.com/research-report/cardiac-monitoring-devices-market
Disposable Oxygen Masks Market: www.datamintelligence.com/research-report/disposable-oxygen-masks-market
Spirometers Market: www.datamintelligence.com/research-report/spirometers-market
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.